Mary Crowley Cancer Research Centers Achieve Dramatic Improvements in Financial Infrastructures With Velos eResearch and Net.Orange Systems
“We are happy to reach this level of accomplishment,” said
As inventor of the revolutionary cOS(TM) (Clinical Operating System), as well as many general and therapeutic-specific technology solutions, Net.Orange began strategic collaboration with
Net.Orange partnered with Velos in 2006 to better serve research institutions. Using Velos eResearch and the Net.Orange cOS(TM),
During the past two years,
“We are equally excited about these achievements,” stated
About the Mary Crowley Cancer Research Centers
Exploring investigational vaccine, gene, and cellular therapies with the goal of expanding treatment options for all cancer patients is the primary mission of the Mary Crowley Cancer Research Centers (
Founded on the imperative of turning data into information and then information into knowledge in a corporate environment, Net.Orange is passionate about how that dynamic is brought into the healthcare arena. The company is committed to the objective of helping customers provide superior quality patient care through better decision making and improved productivity. Net.Orange offers solutions and services that are modular, extensible, and interoperable, with lower cost of ownership and ease of use. The Net.Orange Clinical Operating System(TM) (cOS(TM)) is an intelligent collaboration hub that connects patients, providers, and payers through a consistent common representation. Net.Orange is headquartered in
Velos is the trusted clinical trial management resource for investigators, sponsors and research institutions of all sizes throughout the U.S. Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. The system fundamentally improves the way data is collected, organized and shared. Velos applies rigorous software quality assurance (SQA) standards in its software development process and is the only software vendor in widespread use at investigator sites that is also CFR Part 11 compliant. A pure Internet technology platform, Velos eResearch harnesses advanced powers of the Internet to enable research sites, sponsors, and patients to participate in a secure, integrated system platform. System users are freed of redundant data entry and related time delays associated with most clinical research today. With emphasis on workflow, Velos integrates the clinical, administrative and financial information needs of research management. Velos eTools, a companion product to Velos eResearch, empowers customers by giving them ownership and access to functions such as system configuration, data migrations, custom reporting and third party data submissions. Founded in 1996, Velos is privately held with headquarters in
This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements.
SOURCE Velos, Inc.